Identification and validation of prognostic factors in patients with COVID-19: A retrospective study based on

Sheng Zhang1, Sisi Huang1, Jiao Liu1

  • 1Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin 2nd Road, Shanghai 200025, China.

Insights

Artificial intelligence models accurately predicted COVID-19 mortality using key prognostic factors. These factors include illness severity, age, and various clinical markers, offering valuable insights for patient outcomes.

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Medicine
  • Epidemiology

Background:

  • The COVID-19 pandemic presents a significant global health challenge with high mortality rates.
  • Traditional analytical methods have identified risk factors for COVID-19 mortality, but the application of artificial intelligence (AI) remains less explored.
  • This study addresses the need for advanced analytical approaches to understand COVID-19 prognosis.

Purpose of the Study:

  • To investigate prognostic factors for mortality in COVID-19 patients using artificial intelligence (AI) methods.
  • To compare the predictive performance of AI models with traditional regression techniques.
  • To identify key clinical and demographic indicators associated with adverse outcomes in COVID-19.

Main Methods:

  • A cohort of 1145 COVID-19 patients admitted to Wuhan Infectious Diseases Hospital was analyzed.
  • Data were randomly divided into training (60%) and testing (40%) sets.
  • Least Absolute Shrinkage and Selection Operator (LASSO) regression and LASSO-based Artificial Neural Network (ANN) models were employed to identify mortality predictors, with performance evaluated by Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

  • Nine independent prognostic factors for mortality were identified: severity of illness, age, platelet count, leukocyte count, prealbumin, C-reactive protein (CRP), total bilirubin, APACHE II score, and SOFA score.
  • The LASSO regression model achieved a correct classification rate of 0.98 and an Area Under the ROC Curve (AUC) of 0.980 (training) and 0.990 (testing).
  • The LASSO-based ANN model demonstrated a correct classification rate of 0.990 and an AUC of 0.980 in both training and testing cohorts.

Conclusions:

  • Both LASSO regression and LASSO-based ANN models accurately predicted clinical outcomes in COVID-19 patients.
  • Identified prognostic factors (illness severity, age, platelet count, leukocyte count, prealbumin, CRP, total bilirubin, APACHE II, SOFA scores) are crucial for assessing mortality risk.
  • AI-driven models offer a powerful tool for predicting COVID-19 patient prognosis and informing clinical decision-making.
Abstract